| Date | Form | Description | Docs | XBRL | Pages |
| 01/15/09 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 12/05/08 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/08 | 8-K | Current report filing |
|
2 | |
| 09/19/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
39 | |
| 09/10/08 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 09/02/08 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/08/08 | 8-K | Current report filing |
|
13 | |
| 08/04/08 | DEF 14A | Definitive proxy statements |
|
20 | |
| 06/09/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 03/13/08 | UPLOAD | SEC-generated letter |
|
1 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...